Experimental and Therapeutic Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=810605, encodeId=34d8810605c1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：见刊比oncology letters快太多了，虽然分比oncology letters低，但是中了一篇之后居然收到oncology letters的审稿邀请。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VpuZA6enbYA3iap4AcETtmtuJRscUUzKVKwZUwxY0YrjP9EkgHVjibuassTdHgzRGQlaLnJ0WBGiaOOPPNWqyia5tw/132, createdBy=fd512146641, createdName=a511512345_59251009, createdTime=Wed Aug 19 08:52:45 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811172, encodeId=d8338111e22a, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:870.0 偏重的研究方向：基础研究;心血管;药物 经验分享：有哪位知道收到了final proof多久可以online?从投稿到接收，再到final proof总共耗时8个月，交完版面费没有音讯1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOQaLUnW7A2g1DGYTUlgjQocelibsDGia8kHvJrnmNSv93FtgbxK2O4ysPIvBxHicchSVukBFb4CO2g/132, createdBy=bfb52566233, createdName=sissel84, createdTime=Wed Aug 19 20:58:16 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602378, encodeId=72116023e8b5, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:840.0 偏重的研究方向：干细胞 经验分享：最能体验求生不得求死不能的杂志，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=466e2107034, createdName=myanata9439, createdTime=Tue Jun 16 23:52:42 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602255, encodeId=130460225550, content=大家都用什么方法让他收到邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Sun Jun 14 18:53:05 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188171, encodeId=c41021881e1c3, content=预警了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb62547654, createdName=1253534em30暂无昵称, createdTime=Mon Feb 19 17:11:21 CST 2024, time=2024-02-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2183798, encodeId=2e182183e9856, content=偏重的研究方向：基础研究 经验分享：特别垃圾，接收以后反复修改，也按照杂志要求修改，in production好久了，实在等的急就发了一封邮件询问一下，就收到不适合发表的邮件，太坑人了，说实话一个四区杂志也是影响自己，但是这种浪费时间的杂志千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83erjrmGaaibmR6VQQcnvffdxqKmsTjGsVXfdqStOPgrQibaEFSY1pribOBzxEe8dXQUibQCvkL8uwJAj4w/0, createdBy=979f1937562, createdName=shinoda, createdTime=Thu Jan 25 06:52:52 CST 2024, time=2024-01-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570933, encodeId=86e55e093302, content=这个杂志文字的重复率不能超过多少？降重有没有什么好办法？罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, beContent=罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170627, encodeId=bb1d21e062724, content=看了评论，返修我用了其他公司的润色，我是不是直接无了已经。等着被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Fri Nov 24 01:12:08 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省)]

2020-08-19 a511512345_59251009

审稿速度:3.0 | 投稿命中率:75.0
经验分享：见刊比oncology letters快太多了，虽然分比oncology letters低，但是中了一篇之后居然收到oncology letters的审稿邀请。

113 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=810605, encodeId=34d8810605c1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：见刊比oncology letters快太多了，虽然分比oncology letters低，但是中了一篇之后居然收到oncology letters的审稿邀请。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VpuZA6enbYA3iap4AcETtmtuJRscUUzKVKwZUwxY0YrjP9EkgHVjibuassTdHgzRGQlaLnJ0WBGiaOOPPNWqyia5tw/132, createdBy=fd512146641, createdName=a511512345_59251009, createdTime=Wed Aug 19 08:52:45 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811172, encodeId=d8338111e22a, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:870.0 偏重的研究方向：基础研究;心血管;药物 经验分享：有哪位知道收到了final proof多久可以online?从投稿到接收，再到final proof总共耗时8个月，交完版面费没有音讯1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOQaLUnW7A2g1DGYTUlgjQocelibsDGia8kHvJrnmNSv93FtgbxK2O4ysPIvBxHicchSVukBFb4CO2g/132, createdBy=bfb52566233, createdName=sissel84, createdTime=Wed Aug 19 20:58:16 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602378, encodeId=72116023e8b5, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:840.0 偏重的研究方向：干细胞 经验分享：最能体验求生不得求死不能的杂志，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=466e2107034, createdName=myanata9439, createdTime=Tue Jun 16 23:52:42 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602255, encodeId=130460225550, content=大家都用什么方法让他收到邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Sun Jun 14 18:53:05 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188171, encodeId=c41021881e1c3, content=预警了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb62547654, createdName=1253534em30暂无昵称, createdTime=Mon Feb 19 17:11:21 CST 2024, time=2024-02-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2183798, encodeId=2e182183e9856, content=偏重的研究方向：基础研究 经验分享：特别垃圾，接收以后反复修改，也按照杂志要求修改，in production好久了，实在等的急就发了一封邮件询问一下，就收到不适合发表的邮件，太坑人了，说实话一个四区杂志也是影响自己，但是这种浪费时间的杂志千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83erjrmGaaibmR6VQQcnvffdxqKmsTjGsVXfdqStOPgrQibaEFSY1pribOBzxEe8dXQUibQCvkL8uwJAj4w/0, createdBy=979f1937562, createdName=shinoda, createdTime=Thu Jan 25 06:52:52 CST 2024, time=2024-01-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570933, encodeId=86e55e093302, content=这个杂志文字的重复率不能超过多少？降重有没有什么好办法？罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, beContent=罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170627, encodeId=bb1d21e062724, content=看了评论，返修我用了其他公司的润色，我是不是直接无了已经。等着被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Fri Nov 24 01:12:08 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省)]

2020-08-19 sissel84

审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:870.0
偏重的研究方向：基础研究;心血管;药物
经验分享：有哪位知道收到了final proof多久可以online?从投稿到接收，再到final proof总共耗时8个月，交完版面费没有音讯1个月了

90 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=810605, encodeId=34d8810605c1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：见刊比oncology letters快太多了，虽然分比oncology letters低，但是中了一篇之后居然收到oncology letters的审稿邀请。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VpuZA6enbYA3iap4AcETtmtuJRscUUzKVKwZUwxY0YrjP9EkgHVjibuassTdHgzRGQlaLnJ0WBGiaOOPPNWqyia5tw/132, createdBy=fd512146641, createdName=a511512345_59251009, createdTime=Wed Aug 19 08:52:45 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811172, encodeId=d8338111e22a, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:870.0 偏重的研究方向：基础研究;心血管;药物 经验分享：有哪位知道收到了final proof多久可以online?从投稿到接收，再到final proof总共耗时8个月，交完版面费没有音讯1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOQaLUnW7A2g1DGYTUlgjQocelibsDGia8kHvJrnmNSv93FtgbxK2O4ysPIvBxHicchSVukBFb4CO2g/132, createdBy=bfb52566233, createdName=sissel84, createdTime=Wed Aug 19 20:58:16 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602378, encodeId=72116023e8b5, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:840.0 偏重的研究方向：干细胞 经验分享：最能体验求生不得求死不能的杂志，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=466e2107034, createdName=myanata9439, createdTime=Tue Jun 16 23:52:42 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602255, encodeId=130460225550, content=大家都用什么方法让他收到邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Sun Jun 14 18:53:05 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188171, encodeId=c41021881e1c3, content=预警了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb62547654, createdName=1253534em30暂无昵称, createdTime=Mon Feb 19 17:11:21 CST 2024, time=2024-02-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2183798, encodeId=2e182183e9856, content=偏重的研究方向：基础研究 经验分享：特别垃圾，接收以后反复修改，也按照杂志要求修改，in production好久了，实在等的急就发了一封邮件询问一下，就收到不适合发表的邮件，太坑人了，说实话一个四区杂志也是影响自己，但是这种浪费时间的杂志千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83erjrmGaaibmR6VQQcnvffdxqKmsTjGsVXfdqStOPgrQibaEFSY1pribOBzxEe8dXQUibQCvkL8uwJAj4w/0, createdBy=979f1937562, createdName=shinoda, createdTime=Thu Jan 25 06:52:52 CST 2024, time=2024-01-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570933, encodeId=86e55e093302, content=这个杂志文字的重复率不能超过多少？降重有没有什么好办法？罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, beContent=罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170627, encodeId=bb1d21e062724, content=看了评论，返修我用了其他公司的润色，我是不是直接无了已经。等着被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Fri Nov 24 01:12:08 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省)]

2020-06-22 ms5000000364586422

审稿速度:6.0 | 投稿命中率:50.0
经验分享：接收8个月了，一直in production，发咨询邮件也不回复

106 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=810605, encodeId=34d8810605c1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：见刊比oncology letters快太多了，虽然分比oncology letters低，但是中了一篇之后居然收到oncology letters的审稿邀请。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VpuZA6enbYA3iap4AcETtmtuJRscUUzKVKwZUwxY0YrjP9EkgHVjibuassTdHgzRGQlaLnJ0WBGiaOOPPNWqyia5tw/132, createdBy=fd512146641, createdName=a511512345_59251009, createdTime=Wed Aug 19 08:52:45 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811172, encodeId=d8338111e22a, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:870.0 偏重的研究方向：基础研究;心血管;药物 经验分享：有哪位知道收到了final proof多久可以online?从投稿到接收，再到final proof总共耗时8个月，交完版面费没有音讯1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOQaLUnW7A2g1DGYTUlgjQocelibsDGia8kHvJrnmNSv93FtgbxK2O4ysPIvBxHicchSVukBFb4CO2g/132, createdBy=bfb52566233, createdName=sissel84, createdTime=Wed Aug 19 20:58:16 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602378, encodeId=72116023e8b5, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:840.0 偏重的研究方向：干细胞 经验分享：最能体验求生不得求死不能的杂志，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=466e2107034, createdName=myanata9439, createdTime=Tue Jun 16 23:52:42 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602255, encodeId=130460225550, content=大家都用什么方法让他收到邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Sun Jun 14 18:53:05 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188171, encodeId=c41021881e1c3, content=预警了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb62547654, createdName=1253534em30暂无昵称, createdTime=Mon Feb 19 17:11:21 CST 2024, time=2024-02-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2183798, encodeId=2e182183e9856, content=偏重的研究方向：基础研究 经验分享：特别垃圾，接收以后反复修改，也按照杂志要求修改，in production好久了，实在等的急就发了一封邮件询问一下，就收到不适合发表的邮件，太坑人了，说实话一个四区杂志也是影响自己，但是这种浪费时间的杂志千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83erjrmGaaibmR6VQQcnvffdxqKmsTjGsVXfdqStOPgrQibaEFSY1pribOBzxEe8dXQUibQCvkL8uwJAj4w/0, createdBy=979f1937562, createdName=shinoda, createdTime=Thu Jan 25 06:52:52 CST 2024, time=2024-01-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570933, encodeId=86e55e093302, content=这个杂志文字的重复率不能超过多少？降重有没有什么好办法？罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, beContent=罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170627, encodeId=bb1d21e062724, content=看了评论，返修我用了其他公司的润色，我是不是直接无了已经。等着被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Fri Nov 24 01:12:08 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省)]

2020-07-16 ms8000001135633638

刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么

88 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=810605, encodeId=34d8810605c1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：见刊比oncology letters快太多了，虽然分比oncology letters低，但是中了一篇之后居然收到oncology letters的审稿邀请。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VpuZA6enbYA3iap4AcETtmtuJRscUUzKVKwZUwxY0YrjP9EkgHVjibuassTdHgzRGQlaLnJ0WBGiaOOPPNWqyia5tw/132, createdBy=fd512146641, createdName=a511512345_59251009, createdTime=Wed Aug 19 08:52:45 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811172, encodeId=d8338111e22a, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:870.0 偏重的研究方向：基础研究;心血管;药物 经验分享：有哪位知道收到了final proof多久可以online?从投稿到接收，再到final proof总共耗时8个月，交完版面费没有音讯1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOQaLUnW7A2g1DGYTUlgjQocelibsDGia8kHvJrnmNSv93FtgbxK2O4ysPIvBxHicchSVukBFb4CO2g/132, createdBy=bfb52566233, createdName=sissel84, createdTime=Wed Aug 19 20:58:16 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602378, encodeId=72116023e8b5, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:840.0 偏重的研究方向：干细胞 经验分享：最能体验求生不得求死不能的杂志，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=466e2107034, createdName=myanata9439, createdTime=Tue Jun 16 23:52:42 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602255, encodeId=130460225550, content=大家都用什么方法让他收到邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Sun Jun 14 18:53:05 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188171, encodeId=c41021881e1c3, content=预警了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb62547654, createdName=1253534em30暂无昵称, createdTime=Mon Feb 19 17:11:21 CST 2024, time=2024-02-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2183798, encodeId=2e182183e9856, content=偏重的研究方向：基础研究 经验分享：特别垃圾，接收以后反复修改，也按照杂志要求修改，in production好久了，实在等的急就发了一封邮件询问一下，就收到不适合发表的邮件，太坑人了，说实话一个四区杂志也是影响自己，但是这种浪费时间的杂志千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83erjrmGaaibmR6VQQcnvffdxqKmsTjGsVXfdqStOPgrQibaEFSY1pribOBzxEe8dXQUibQCvkL8uwJAj4w/0, createdBy=979f1937562, createdName=shinoda, createdTime=Thu Jan 25 06:52:52 CST 2024, time=2024-01-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570933, encodeId=86e55e093302, content=这个杂志文字的重复率不能超过多少？降重有没有什么好办法？罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, beContent=罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170627, encodeId=bb1d21e062724, content=看了评论，返修我用了其他公司的润色，我是不是直接无了已经。等着被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Fri Nov 24 01:12:08 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省)]

2020-06-16 myanata9439

审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:840.0
偏重的研究方向：干细胞
经验分享：最能体验求生不得求死不能的杂志，没有之一

45 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=810605, encodeId=34d8810605c1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：见刊比oncology letters快太多了，虽然分比oncology letters低，但是中了一篇之后居然收到oncology letters的审稿邀请。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VpuZA6enbYA3iap4AcETtmtuJRscUUzKVKwZUwxY0YrjP9EkgHVjibuassTdHgzRGQlaLnJ0WBGiaOOPPNWqyia5tw/132, createdBy=fd512146641, createdName=a511512345_59251009, createdTime=Wed Aug 19 08:52:45 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811172, encodeId=d8338111e22a, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:870.0 偏重的研究方向：基础研究;心血管;药物 经验分享：有哪位知道收到了final proof多久可以online?从投稿到接收，再到final proof总共耗时8个月，交完版面费没有音讯1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOQaLUnW7A2g1DGYTUlgjQocelibsDGia8kHvJrnmNSv93FtgbxK2O4ysPIvBxHicchSVukBFb4CO2g/132, createdBy=bfb52566233, createdName=sissel84, createdTime=Wed Aug 19 20:58:16 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602378, encodeId=72116023e8b5, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:840.0 偏重的研究方向：干细胞 经验分享：最能体验求生不得求死不能的杂志，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=466e2107034, createdName=myanata9439, createdTime=Tue Jun 16 23:52:42 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602255, encodeId=130460225550, content=大家都用什么方法让他收到邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Sun Jun 14 18:53:05 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188171, encodeId=c41021881e1c3, content=预警了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb62547654, createdName=1253534em30暂无昵称, createdTime=Mon Feb 19 17:11:21 CST 2024, time=2024-02-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2183798, encodeId=2e182183e9856, content=偏重的研究方向：基础研究 经验分享：特别垃圾，接收以后反复修改，也按照杂志要求修改，in production好久了，实在等的急就发了一封邮件询问一下，就收到不适合发表的邮件，太坑人了，说实话一个四区杂志也是影响自己，但是这种浪费时间的杂志千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83erjrmGaaibmR6VQQcnvffdxqKmsTjGsVXfdqStOPgrQibaEFSY1pribOBzxEe8dXQUibQCvkL8uwJAj4w/0, createdBy=979f1937562, createdName=shinoda, createdTime=Thu Jan 25 06:52:52 CST 2024, time=2024-01-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570933, encodeId=86e55e093302, content=这个杂志文字的重复率不能超过多少？降重有没有什么好办法？罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, beContent=罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170627, encodeId=bb1d21e062724, content=看了评论，返修我用了其他公司的润色，我是不是直接无了已经。等着被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Fri Nov 24 01:12:08 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省)]

2020-06-14 李晓刚

大家都用什么方法让他收到邮件呢？

0 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=810605, encodeId=34d8810605c1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：见刊比oncology letters快太多了，虽然分比oncology letters低，但是中了一篇之后居然收到oncology letters的审稿邀请。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VpuZA6enbYA3iap4AcETtmtuJRscUUzKVKwZUwxY0YrjP9EkgHVjibuassTdHgzRGQlaLnJ0WBGiaOOPPNWqyia5tw/132, createdBy=fd512146641, createdName=a511512345_59251009, createdTime=Wed Aug 19 08:52:45 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811172, encodeId=d8338111e22a, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:870.0 偏重的研究方向：基础研究;心血管;药物 经验分享：有哪位知道收到了final proof多久可以online?从投稿到接收，再到final proof总共耗时8个月，交完版面费没有音讯1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOQaLUnW7A2g1DGYTUlgjQocelibsDGia8kHvJrnmNSv93FtgbxK2O4ysPIvBxHicchSVukBFb4CO2g/132, createdBy=bfb52566233, createdName=sissel84, createdTime=Wed Aug 19 20:58:16 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602378, encodeId=72116023e8b5, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:840.0 偏重的研究方向：干细胞 经验分享：最能体验求生不得求死不能的杂志，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=466e2107034, createdName=myanata9439, createdTime=Tue Jun 16 23:52:42 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602255, encodeId=130460225550, content=大家都用什么方法让他收到邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Sun Jun 14 18:53:05 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188171, encodeId=c41021881e1c3, content=预警了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb62547654, createdName=1253534em30暂无昵称, createdTime=Mon Feb 19 17:11:21 CST 2024, time=2024-02-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2183798, encodeId=2e182183e9856, content=偏重的研究方向：基础研究 经验分享：特别垃圾，接收以后反复修改，也按照杂志要求修改，in production好久了，实在等的急就发了一封邮件询问一下，就收到不适合发表的邮件，太坑人了，说实话一个四区杂志也是影响自己，但是这种浪费时间的杂志千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83erjrmGaaibmR6VQQcnvffdxqKmsTjGsVXfdqStOPgrQibaEFSY1pribOBzxEe8dXQUibQCvkL8uwJAj4w/0, createdBy=979f1937562, createdName=shinoda, createdTime=Thu Jan 25 06:52:52 CST 2024, time=2024-01-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570933, encodeId=86e55e093302, content=这个杂志文字的重复率不能超过多少？降重有没有什么好办法？罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, beContent=罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170627, encodeId=bb1d21e062724, content=看了评论，返修我用了其他公司的润色，我是不是直接无了已经。等着被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Fri Nov 24 01:12:08 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省)]

2024-02-19 1253534em30暂无昵称来自山东省

预警了，怎么办

26 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=810605, encodeId=34d8810605c1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：见刊比oncology letters快太多了，虽然分比oncology letters低，但是中了一篇之后居然收到oncology letters的审稿邀请。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VpuZA6enbYA3iap4AcETtmtuJRscUUzKVKwZUwxY0YrjP9EkgHVjibuassTdHgzRGQlaLnJ0WBGiaOOPPNWqyia5tw/132, createdBy=fd512146641, createdName=a511512345_59251009, createdTime=Wed Aug 19 08:52:45 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811172, encodeId=d8338111e22a, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:870.0 偏重的研究方向：基础研究;心血管;药物 经验分享：有哪位知道收到了final proof多久可以online?从投稿到接收，再到final proof总共耗时8个月，交完版面费没有音讯1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOQaLUnW7A2g1DGYTUlgjQocelibsDGia8kHvJrnmNSv93FtgbxK2O4ysPIvBxHicchSVukBFb4CO2g/132, createdBy=bfb52566233, createdName=sissel84, createdTime=Wed Aug 19 20:58:16 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602378, encodeId=72116023e8b5, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:840.0 偏重的研究方向：干细胞 经验分享：最能体验求生不得求死不能的杂志，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=466e2107034, createdName=myanata9439, createdTime=Tue Jun 16 23:52:42 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602255, encodeId=130460225550, content=大家都用什么方法让他收到邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Sun Jun 14 18:53:05 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188171, encodeId=c41021881e1c3, content=预警了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb62547654, createdName=1253534em30暂无昵称, createdTime=Mon Feb 19 17:11:21 CST 2024, time=2024-02-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2183798, encodeId=2e182183e9856, content=偏重的研究方向：基础研究 经验分享：特别垃圾，接收以后反复修改，也按照杂志要求修改，in production好久了，实在等的急就发了一封邮件询问一下，就收到不适合发表的邮件，太坑人了，说实话一个四区杂志也是影响自己，但是这种浪费时间的杂志千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83erjrmGaaibmR6VQQcnvffdxqKmsTjGsVXfdqStOPgrQibaEFSY1pribOBzxEe8dXQUibQCvkL8uwJAj4w/0, createdBy=979f1937562, createdName=shinoda, createdTime=Thu Jan 25 06:52:52 CST 2024, time=2024-01-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570933, encodeId=86e55e093302, content=这个杂志文字的重复率不能超过多少？降重有没有什么好办法？罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, beContent=罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170627, encodeId=bb1d21e062724, content=看了评论，返修我用了其他公司的润色，我是不是直接无了已经。等着被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Fri Nov 24 01:12:08 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省)]

2024-01-25 shinoda 来自江苏省

偏重的研究方向：基础研究
经验分享：特别垃圾，接收以后反复修改，也按照杂志要求修改，in production好久了，实在等的急就发了一封邮件询问一下，就收到不适合发表的邮件，太坑人了，说实话一个四区杂志也是影响自己，但是这种浪费时间的杂志千万别投

28 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=810605, encodeId=34d8810605c1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：见刊比oncology letters快太多了，虽然分比oncology letters低，但是中了一篇之后居然收到oncology letters的审稿邀请。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VpuZA6enbYA3iap4AcETtmtuJRscUUzKVKwZUwxY0YrjP9EkgHVjibuassTdHgzRGQlaLnJ0WBGiaOOPPNWqyia5tw/132, createdBy=fd512146641, createdName=a511512345_59251009, createdTime=Wed Aug 19 08:52:45 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811172, encodeId=d8338111e22a, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:870.0 偏重的研究方向：基础研究;心血管;药物 经验分享：有哪位知道收到了final proof多久可以online?从投稿到接收，再到final proof总共耗时8个月，交完版面费没有音讯1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOQaLUnW7A2g1DGYTUlgjQocelibsDGia8kHvJrnmNSv93FtgbxK2O4ysPIvBxHicchSVukBFb4CO2g/132, createdBy=bfb52566233, createdName=sissel84, createdTime=Wed Aug 19 20:58:16 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602378, encodeId=72116023e8b5, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:840.0 偏重的研究方向：干细胞 经验分享：最能体验求生不得求死不能的杂志，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=466e2107034, createdName=myanata9439, createdTime=Tue Jun 16 23:52:42 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602255, encodeId=130460225550, content=大家都用什么方法让他收到邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Sun Jun 14 18:53:05 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188171, encodeId=c41021881e1c3, content=预警了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb62547654, createdName=1253534em30暂无昵称, createdTime=Mon Feb 19 17:11:21 CST 2024, time=2024-02-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2183798, encodeId=2e182183e9856, content=偏重的研究方向：基础研究 经验分享：特别垃圾，接收以后反复修改，也按照杂志要求修改，in production好久了，实在等的急就发了一封邮件询问一下，就收到不适合发表的邮件，太坑人了，说实话一个四区杂志也是影响自己，但是这种浪费时间的杂志千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83erjrmGaaibmR6VQQcnvffdxqKmsTjGsVXfdqStOPgrQibaEFSY1pribOBzxEe8dXQUibQCvkL8uwJAj4w/0, createdBy=979f1937562, createdName=shinoda, createdTime=Thu Jan 25 06:52:52 CST 2024, time=2024-01-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570933, encodeId=86e55e093302, content=这个杂志文字的重复率不能超过多少？降重有没有什么好办法？罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, beContent=罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170627, encodeId=bb1d21e062724, content=看了评论，返修我用了其他公司的润色，我是不是直接无了已经。等着被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Fri Nov 24 01:12:08 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省)]

2019-05-14 ms5000000364586422

这个杂志文字的重复率不能超过多少？降重有没有什么好办法？罗磊 2019-04-22 00:00:00 发表:
我的一个月就接收了

罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了

116 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=810605, encodeId=34d8810605c1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：见刊比oncology letters快太多了，虽然分比oncology letters低，但是中了一篇之后居然收到oncology letters的审稿邀请。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VpuZA6enbYA3iap4AcETtmtuJRscUUzKVKwZUwxY0YrjP9EkgHVjibuassTdHgzRGQlaLnJ0WBGiaOOPPNWqyia5tw/132, createdBy=fd512146641, createdName=a511512345_59251009, createdTime=Wed Aug 19 08:52:45 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811172, encodeId=d8338111e22a, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:870.0 偏重的研究方向：基础研究;心血管;药物 经验分享：有哪位知道收到了final proof多久可以online?从投稿到接收，再到final proof总共耗时8个月，交完版面费没有音讯1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOQaLUnW7A2g1DGYTUlgjQocelibsDGia8kHvJrnmNSv93FtgbxK2O4ysPIvBxHicchSVukBFb4CO2g/132, createdBy=bfb52566233, createdName=sissel84, createdTime=Wed Aug 19 20:58:16 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602378, encodeId=72116023e8b5, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:840.0 偏重的研究方向：干细胞 经验分享：最能体验求生不得求死不能的杂志，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=466e2107034, createdName=myanata9439, createdTime=Tue Jun 16 23:52:42 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602255, encodeId=130460225550, content=大家都用什么方法让他收到邮件呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Sun Jun 14 18:53:05 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188171, encodeId=c41021881e1c3, content=预警了，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb62547654, createdName=1253534em30暂无昵称, createdTime=Mon Feb 19 17:11:21 CST 2024, time=2024-02-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2183798, encodeId=2e182183e9856, content=偏重的研究方向：基础研究 经验分享：特别垃圾，接收以后反复修改，也按照杂志要求修改，in production好久了，实在等的急就发了一封邮件询问一下，就收到不适合发表的邮件，太坑人了，说实话一个四区杂志也是影响自己，但是这种浪费时间的杂志千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83erjrmGaaibmR6VQQcnvffdxqKmsTjGsVXfdqStOPgrQibaEFSY1pribOBzxEe8dXQUibQCvkL8uwJAj4w/0, createdBy=979f1937562, createdName=shinoda, createdTime=Thu Jan 25 06:52:52 CST 2024, time=2024-01-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=570933, encodeId=86e55e093302, content=这个杂志文字的重复率不能超过多少？降重有没有什么好办法？罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, beContent=罗磊 2019-04-22 00:00:00 发表: 我的一个月就接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170627, encodeId=bb1d21e062724, content=看了评论，返修我用了其他公司的润色，我是不是直接无了已经。等着被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Fri Nov 24 01:12:08 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省)]

2023-11-24 ms8000000748330837 来自广东省

看了评论，返修我用了其他公司的润色，我是不是直接无了已经。等着被拒稿了

34 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务